Significance of second progression‐free survival in patients with advanced urothelial cancer who received platinum‐based combination chemotherapy followed by pembrolizumab-Reference-Cited by-同舟云学术

Significance of second progression‐free survival in patients with advanced urothelial cancer who received platinum‐based combination chemotherapy followed by pembrolizumab

Published:2022-12-27 Issue: Volume: Page:
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Sato Ryo¹^ORCID,Inamoto Teruo²,Matsushita Yuto¹^ORCID,Takemura Ayana¹,Uchimoto Taizo²,Sano Asuka¹,Tanaka Hiroki¹,Ishikawa Gaku¹,Watanabe Kyohei¹^ORCID,Watanabe Hiromitsu¹,Tamura Keita¹,Motoyama Daisuke¹^ORCID,Sugiyama Takayuki¹,Otsuka Atsushi¹^ORCID,Harada Ken‐ichi³^ORCID,Azuma Haruhito²,Miyake Hideaki¹

Affiliation:

1. Department of Urology Hamamatsu University School of Medicine Hamamatsu Japan

2. Department of Urology Osaka Medical and Pharmaceutical University Takatsuki Japan

3. Department of Urology University of Occupational and Environmental Health Kitakyushu Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.15133

Reference25 articles.

1. Cancer statistics, 2019;Siegel RL;CA Cancer J Clin,2019

2. A molecular taxonomy for urothelial carcinoma;Sjödahl G;Clin Caner Res,2012

3. The efficacy of second‐line chemotherapy for advanced or metastatic urothelial cancer;Naito R;Anticancer Res,2020

4. Recent advances in medical therapy for metastatic urothelial cancer;Yuasa T;Int J Clin Oncol,2018

5. The current landscape of immune checkpoint inhibition for solid malignancies;Keung EZ;Surg Oncol Clin N Am,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial Comment to Significance of second progression‐free survival in patients with advanced urothelial cancer who received platinum‐based combination chemotherapy followed by pembrolizumab;International Journal of Urology;2023-02-14